Cambria Investment Management’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-753
Closed -$52.9K 317
2023
Q1
$52.9K Sell
753
-84
-10% -$7.79K ﹤0.01% 275
2022
Q4
$68.4K Buy
837
+42
+5% +$4.23K 0.01% 269
2022
Q3
$64K Buy
795
+150
+23% +$21.5K 0.01% 246
2022
Q2
$102K Hold
645
0.01% 260
2022
Q1
$241K Buy
645
+141
+28% +$47.6K 0.03% 237
2021
Q4
$196K Sell
504
-38
-7% -$22.1K 0.03% 254
2021
Q3
$406K Buy
542
+25
+5% +$20.9K 0.07% 160
2021
Q2
$539K Buy
517
+253
+96% +$303K 0.09% 157
2021
Q1
$393K Buy
264
+79
+43% +$115K 0.08% 160
2020
Q4
$197K Buy
+185
New +$168K 0.07% 168

Other funds holding YCBD

Cambria Investment Management's YCBD Position: Q2 2023 in Review

Cambria Investment Management sold out of cbdMD (YCBD) in Q2 2023, closing a stake of 753 shares — an estimated $52.9K sold.

Cambria Investment Management first reported a position in YCBD in Q4 2020 and held it in 10 quarters. The position peaked at $539K in Q2 2021. 20 funds tracked by Wall St. Rank hold YCBD as of Q2 2023.

  • Cambria Investment Management reported no remaining cbdMD position as of Q2 2023 after selling out during the quarter.
  • Cambria Investment Management sold 753 cbdMD shares in Q2 2023, an estimated $52.9K.
  • Cambria Investment Management first reported a position in cbdMD in Q4 2020 and held it in 10 quarters.
  • Cambria Investment Management's cbdMD position peaked at $539K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held cbdMD as of Q2 2023.

Based on Cambria Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.